Atlas Trials

A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO

Clinical trial NCT00567697 · COMPLETED

Trial details

NCT number
NCT00567697
Sponsor
Aleris Helse
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Central Retinal Vein OcclusionMacular Edema
Start date
2007-03-01
Primary completion
2008-10-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.